Jump to any asset
873 assets, updated daily
Head-to-head · Stock vs Stock
Boston Scientific vs Medtronic
vs
BSX vs MDT: the verdict
How BSX and MDT compare today, and what CleaRank Financial AI makes of it.
The verdict
CleaRank Financial AI favours
MDT
BSX
MDT
63/100
AI score
79/100
-56.0%
1-year change
+1.2%
25.1%
Volatility (30d, yearly)
29.3%
53.2
RSI (14-day)
57.9
18.3x
P/E ratio
23.3x
None
Dividend yield
3.02%
The verdict
Medtronic (MDT) comes out ahead on CleaRank's model, scoring 79/100 (Buy) against 63/100 (Buy) for Boston Scientific (BSX). The widest gap is the trend: for MDT, the price is 7.47% above its 200-day average and 3.67% above its 50-day average, and the 50-day average is 3.67% above the 200-day. For BSX, the price is 21.33% below its 200-day average and 0.47% below its 50-day average, and the 50-day average is 21.24% below the 200-day.
Outlook
BSX would need to regain its 50-day average at $45.54 and its 200-day at $57.83 to turn its downtrend. MDT's uptrend holds while it stays above its 50-day average at $91.44 and its 200-day at $88.20.
Price, side by side
Both prices start at 0% on the first day of the period you pick, so the moves compare directly.
Rebased price
-5%0%+5%+10%+6.9%+3.8%
Oct '26
-10%-5%0%+5%+10%+15%+13%+0.1%
Aug '26Sep '26Oct '26
-30%-20%-10%0%+10%+20%+14%-24%
May '26Jun '26Jul '26Aug '26Sep '26Oct '26
-60%-40%-20%0%+1.2%-55%
Nov '25Jan '26Mar '26Jun '26Aug '26Oct '26
-40%-20%0%+20%+40%+12%-42%
Sep '24Feb '25Jul '25Dec '25May '26Oct '26
Over 1 year: BSX lost 54.9% and MDT gained 1.2%, a gap of 56.1 points in MDT's favour.
Valuation and profitability
What each costs relative to its earnings and sales, and how much of its revenue it keeps.
Side by side
Valuation
Lower multiples mean you pay less for each dollar of earnings or sales.
BSX
MDT
$65.3B
Market cap
$121.2B
18.3x
P/E ratio
23.3x
3.1x
Price / sales
3.3x
2.7x
Price / book
2.4x
13.8x
EV / EBITDA
13.6x
Profitability
How much of each dollar of revenue becomes profit, and how hard the capital works.
BSX
MDT
+7.5%
Revenue growth (quarter, y/y)
+9.9%
17.5%
Net margin
13.9%
15.3%
Return on equity
10.6%
6.2%
Return on assets
5.1%
0.50
Debt / equity
0.55
On valuation
MDT carries the higher trailing P/E, 23.29 against 18.33 for BSX. Both sit at a discount to peers, measured against a Healthcare median of 31.9. Looking at sales, MDT is priced higher, at 3.25 times against 3.15. In size, MDT is the bigger company, with a market value of $121.2B versus $66.2B.
On profitability
BSX keeps more of its sales as profit, with a net margin of 17.50% against 13.93%. BSX also earns the higher return on equity, 15.34% against 10.65%. In the latest quarter, year on year, revenue grew 7.53% at BSX and grew 9.86% at MDT. No dividend is reported in our data for BSX. MDT has a trailing dividend yield of 3.02%.
Earnings reality check
BSX
BSX beat the estimate in 8 of its last 8 reports (latest Jul '26); the shares fell the next session after 4 of those beats.
Surprise
Next session
Feb '25Jul '25Feb '26Jul '26
MDT
MDT beat the estimate in 5 of its last 5 reports (latest Sep '26); the shares fell the next session after 2 of those beats.
Surprise
Next session
May '25Aug '25Nov '25Feb '26Sep '26
Momentum and sentiment
The indicators behind each AI score, side by side.
Indicators side by side
BSX
MDT
63/100
AI score
79/100
53.2
RSI (14-day)
57.9
-0.5%
Price against 50-day average
+3.7%
-21.3%
Price against 200-day average
+7.5%
Technicals
BSX is in a downtrend, trading 0.47% below its 50-day average and 21.33% below its 200-day average. Its 14-day RSI is 57.2, in the neutral zone, with the MACD line positive. MDT is in an uptrend, trading 3.67% above its 50-day average and 7.47% above its 200-day average. Its 14-day RSI is 57.9, in the neutral zone, with the MACD line positive. MDT sits higher in its 52-week range, at 65% against 6% for BSX.
Sentiment
Of the 31 analysts covering BSX, 25 rate it buy, 6 hold and 0 sell; their median target is $57.00, 25.9% above the price. Of the 30 analysts covering MDT, 20 rate it buy, 10 hold and 0 sell; their median target is $106.00, 11.8% above the price.
Risk and practical tips
How much each moves, how much return each has paid for that risk, and what to watch if you hold either.
Risk measures
BSX
MDT
25.1%
Volatility (30d, yearly)
29.3%
0.58
Beta against the S&P 500
0.57
-0.82
Sharpe ratio
0.14
Risk
Both stocks make similar moves on a typical day, with an average daily move of 1.52% for BSX and 1.65% for MDT. Measured against the S&P 500, BSX's beta is 0.58 and MDT's is 0.57. In the price history, BSX's worst fall was 61.5%, running from September 2025 to October 2026. MDT's worst fall was 44.4%, from September 2021 to November 2023. BSX had the deeper of the two worst falls, and the other measures we track are close for the pair.
ProTips
- For BSX, watch the 50-day SMA at $45.54 above the price and the 20-day EMA at $44.35 below it.
- For MDT, watch the 52-week high at $106.33 above the price and the 20-day EMA at $92.52 below it.
BSX vs MDT: long-term scenarios
Simulated paths from each price history. A range of outcomes, not a forecast.
Simulated growth of $10,000
$10K$20K$30K$40K$50K$60K$60.9K$38.7K$19.5K$14.8K
202620282030203220342036
BSX
MDT
$6,268
Downside, 2036 (10th)
$5,648
$19,536
Base case, 2036 (median)
$14,784
$60,891
Upside, 2036 (90th)
$38,695
In the median simulated path, $10,000 in BSX grows to about $19,500 and $10,000 in MDT to about $14,800 by 2036. The paths come from each asset's own historical volatility and trend; they are statistical outcomes, not forecasts.
Trade plans for both
Entry, stop and target levels from each moving average and its volatility. Educational, not advice.
Actionable Trade Plans
Select Your Trade Bias
Risk Tolerance
Conservative
3%
Aggressive
Portfolio Value
$
✎
Position Size: $200 - $300 per asset
BSX
Current: $45.08
ENTRY ZONES
Conservative
$42.82
Aggressive
$45.08
RISK MANAGEMENT
STOP LOSS
$41.54
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5% from current
$47.33
+10% from current
$49.58
+15% from current
$51.84
MDT
Current: $94.79
ENTRY ZONES
Conservative
$90.05
Aggressive
$94.79
RISK MANAGEMENT
STOP LOSS
$87.35
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5% from current
$99.53
+10% from current
$104.27
+15% from current
$109.01
Calculate Your Trade
Disclaimer
The content is for educational purposes only. The verdict weighs trend, valuation and risk together. Trading involves risk of loss. Note: The AI favored MDT based on its price trend, on today's data.
BSX vs MDT: questions people ask
Answered from the figures on this page.
Frequently Asked Questions
Which is better, BSX or MDT?+
On CleaRank's model MDT scores higher, 79/100 (Buy) against 63/100 (Buy) for BSX. This describes the data on this page and is not a personal recommendation.
Which has performed better over the past year, BSX or MDT?+
MDT has done better: its price rose 1.20% over the past year, while BSX fell 55.38%.
Which is cheaper on earnings, BSX or MDT?+
BSX has the lower trailing P/E, at 18.33 compared with 23.29 for MDT.
Which pays more income, BSX or MDT?+
MDT offers the higher yield at 3.02%, while no yield is reported for BSX. A yield is the payout divided by the price, so it moves whenever either of those does.
Which is riskier, BSX or MDT?+
BSX has had the deeper worst fall; on the other measures we track the two are close. Average daily move: 1.52% for BSX, 1.65% for MDT. Beta against the S&P 500: 0.58 for BSX, 0.57 for MDT. Worst fall in the price history: 61.5% for BSX, 44.4% for MDT.
Which has stronger momentum right now, BSX or MDT?+
MDT has the higher 14-day RSI, 57.9 (neutral) against 57.2 (neutral) for BSX. Both MACD lines are positive. Readings above 70 or below 30 mark stretched momentum.
Which is the bigger company, BSX or MDT?+
MDT is the larger business by market value: $121.2B against $66.2B for BSX.
What do analysts say about BSX and MDT?+
Of BSX's 31 analysts, 25 rate it buy, and the median target sits 25.9% above the price. For MDT, 20 of 30 analysts rate it buy, and the median target is 11.8% above the price.
How would $10,000 have grown in BSX or MDT?+
Invested in October 2016, $10,000 would be worth $20,684 today in BSX and $15,267 in MDT.